Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Schizophrenia News

News
Schizophrenia Outcomes Better With Case-Managed Care in the Community
11/16/2021
Jolynn Tumolo
Research shows patients with severe schizophrenia treated in a community-based, case-managed program had a higher rate of treatment retention, fewer hospital admissions and suicide attempts, and less clinical severity.
Research shows patients with severe schizophrenia treated in a community-based, case-managed program had a higher rate of treatment retention, fewer hospital admissions and suicide attempts, and less clinical severity.
Research shows patients with...
11/16/2021
Psych Congress Network
News
Meta-Analysis IDs Best Psychotherapy Interventions for Schizophrenia Relapse Prevention
10/27/2021
Jolynn Tumolo
Family interventions, family psychoeducation, and cognitive behavioral therapy provide clear, robust benefits for relapse prevention in people with schizophrenia, according to findings from a systematic review and network meta-analysis.
Family interventions, family psychoeducation, and cognitive behavioral therapy provide clear, robust benefits for relapse prevention in people with schizophrenia, according to findings from a systematic review and network meta-analysis.
Family interventions, family...
10/27/2021
Psych Congress Network

Advertisement

News
When Faced with the Term “Schizophrenic,” Attitudes of Mental Health Professionals Shift
10/14/2021
Jolynn Tumolo
According to a recent study, practicing mental health counselors and counselors in training who received a survey referring to people with schizophrenia as “schizophrenic” had attitudes that were less benevolent, more authoritarian, and...
According to a recent study, practicing mental health counselors and counselors in training who received a survey referring to people with schizophrenia as “schizophrenic” had attitudes that were less benevolent, more authoritarian, and...
According to a recent study,...
10/14/2021
Psych Congress Network
News
Suicide Rate Quadrupled in US Adults With Schizophrenia
06/02/2021
Adults with schizophrenia have a suicide rate 4.5 times higher than the general US population, according to a study published online ahead of print in JAMA Psychiatry.
Adults with schizophrenia have a suicide rate 4.5 times higher than the general US population, according to a study published online ahead of print in JAMA Psychiatry.
Adults with schizophrenia have a...
06/02/2021
Psych Congress Network
News
FDA Approves Treatment for Adults With Schizophrenia and Bipolar I Disorder
06/01/2021
Meagan Thistle
The US Food and Drug Administration has approved Alkermes Plc's LYBALVI to treat adults with schizophrenia and adults with bipolar I disorder and offers the antipsychotic efficacy of olanzapine with less weight gain.
The US Food and Drug Administration has approved Alkermes Plc's LYBALVI to treat adults with schizophrenia and adults with bipolar I disorder and offers the antipsychotic efficacy of olanzapine with less weight gain.
The US Food and Drug...
06/01/2021
Psych Congress Network

Advertisement

News
Three Quarters of Patients With Schizophrenia Report Substance Use, Chart Review Finds
05/19/2021
A review of electronic medical records of patients with schizophrenia spectrum disorders in a community teaching hospital’s psychiatric unit found that more than three-quarters used substances such as tobacco and cannabis.
A review of electronic medical records of patients with schizophrenia spectrum disorders in a community teaching hospital’s psychiatric unit found that more than three-quarters used substances such as tobacco and cannabis.
A review of electronic medical...
05/19/2021
Psych Congress Network
News
Study Finds Evidence of Bartonella Infection in Blood of Patients With Schizophrenia
05/03/2021
A pilot study found evidence of Bartonella infection in the blood of participants with schizophrenia, fueling researchers’ hypothesis that there may be a connection between bacterial infection and neuropsychiatric disease.
A pilot study found evidence of Bartonella infection in the blood of participants with schizophrenia, fueling researchers’ hypothesis that there may be a connection between bacterial infection and neuropsychiatric disease.
A pilot study found evidence of...
05/03/2021
Psych Congress Network
News
Schizophrenia, Personality Disorders Present Highest Disability Burdens in Mental Health
03/31/2021
Schizophrenia and personality disorders had the highest burdens of disability among individuals with mental health or substance use disorders, according to a new analysis published in The Lancet Psychiatry.
Schizophrenia and personality disorders had the highest burdens of disability among individuals with mental health or substance use disorders, according to a new analysis published in The Lancet Psychiatry.
Schizophrenia and personality...
03/31/2021
Psych Congress Network

Advertisement

News
Xanomeline-Trospium Improves Schizophrenia Symptoms in Phase 2 Trial
03/11/2021
Positive and Negative Syndrome Scale total scores dropped an additional 11.6 points in patients with schizophrenia who received combination xanomeline-trospium, compared with placebo, according to a published study.
Positive and Negative Syndrome Scale total scores dropped an additional 11.6 points in patients with schizophrenia who received combination xanomeline-trospium, compared with placebo, according to a published study.
Positive and Negative Syndrome...
03/11/2021
Psych Congress Network
News
Metabolic Disorders Linked With Greater Cognitive Deficits in People With Schizophrenia
03/09/2021
Metabolic syndrome, diabetes, and hypertension are linked with greater global cognitive impairment in people with schizophrenia, according to a systematic review and meta-analysis published online ahead of print in JAMA Psychiatry.
Metabolic syndrome, diabetes, and hypertension are linked with greater global cognitive impairment in people with schizophrenia, according to a systematic review and meta-analysis published online ahead of print in JAMA Psychiatry.
Metabolic syndrome, diabetes,...
03/09/2021
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use